Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Fox Chase Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center